LIMK1 and prostate carcinoma: The level of expression of LIMK1 achieved in our experiment was either parallel to or less than that noted in advanced prostate tumors and in PC3 prostate cancer cells; this suggests that over expression of LIMK1 in prostate tumors may suffice to elicit the biological effects noted here.